Connective Tissue Growth Factor is Induced in Bleomycin-induced Skin Scleroderma

Overview

Journal J Cell Commun Signal

Date 2009 Nov 17

PMID 19916059

Citations 24

Authors

Shangxi Liu

Reza Taghavi

Andrew Leask

Affiliations

Soon will be listed here.

Abstract

The origin of fibrotic cells within connective tissue is unclear. For example, the extent to which microvascular pericytes contribute to the number of myofibroblasts present in dermal fibrosis in uncertain. Connective tissue growth factor (CTGF/CCN2) is a marker and mediator of fibrosis. In this report, we use an antibody recognizing CCN2 to assess the cell types in mouse dermis which express CCN2 in the bleomycin model of skin scleroderma. Control (PBS injected) and fibrotic (bleomycin-injected) dermis was examined for CCN2, alpha-smooth muscle actin (alpha-SMA) (to detect myofibroblasts), and NG2 (to detect pericytes) expression. Consistent with previously published data, CCN2 expression was largely absent in the dermis of control mice. However, upon exposure to bleomycin, CCN2 was observed in the dermis. Cells that expressed CCN2 were alpha-SMA-expressing myofibroblasts. Approximately 85% of myofibroblasts were NG2-positive, CCN2-expressing pericytes, indicating that pericytes significantly contributed to the presence of myofibroblasts in sclerotic dermis. Thus CCN2 is induced in fibrotic skin, correlating with the induction of myofibroblast induction. Moreover, CCN2-expressing pericytes significantly contribute to the appearance of myofibroblasts in bleomycin-induced skin scleroderma.

Citing Articles

Qin Z, He T, Guo C, Quan T JID Innov. 2022; 2(3):100111.

PMID: 35480397 PMC: 9035808. DOI: 10.1016/j.xjidi.2022.100111.

New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy.

Romano E, Rosa I, Fioretto B, Matucci-Cerinic M, Manetti M Life (Basel). 2021; 11(7).

PMID: 34202703 PMC: 8307837. DOI: 10.3390/life11070610.

Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.

Tam A, Horwell A, Trinder S, Khan K, Xu S, Ong V Int J Biochem Cell Biol. 2021; 134:105961.

PMID: 33662577 PMC: 8111417. DOI: 10.1016/j.biocel.2021.105961.

Generation of a novel mouse strain with fibroblast-specific expression of Cre recombinase.

Alam J, Musiime M, Romaine A, Sawant M, Melleby A, Lu N Matrix Biol Plus. 2021; 8:100045.

PMID: 33543038 PMC: 7852330. DOI: 10.1016/j.mbplus.2020.100045.

CCN2/CTGF promotor activity in the developing and adult mouse eye.

Dillinger A, Kuespert S, Froemel F, Tamm E, Fuchshofer R Cell Tissue Res. 2021; 384(3):625-641.

PMID: 33512643 PMC: 8211604. DOI: 10.1007/s00441-020-03332-4.

References

Ozerdem U, Stallcup W . Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis. 2004; 7(3):269-76. PMC: 1350818. DOI: 10.1007/s10456-004-4182-6. View

Wu M, Varga J . In perspective: murine models of scleroderma. Curr Rheumatol Rep. 2008; 10(3):173-82. DOI: 10.1007/s11926-008-0030-9. View

Salvucci O, Maric D, Economopoulou M, Sakakibara S, Merlin S, Follenzi A . EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood. 2009; 114(8):1707-16. PMC: 2731645. DOI: 10.1182/blood-2008-12-192294. View

Rajkumar V, Shiwen X, Bostrom M, Leoni P, Muddle J, Ivarsson M . Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol. 2006; 169(6):2254-65. PMC: 1762470. DOI: 10.2353/ajpath.2006.060196. View

Leask A, Abraham D . All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci. 2006; 119(Pt 23):4803-10. DOI: 10.1242/jcs.03270. View

Grotendorst G . Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 1998; 8(3):171-9. DOI: 10.1016/s1359-6101(97)00010-5. View

Lasky J, Ortiz L, Tonthat B, Hoyle G, Corti M, Athas G . Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol. 1998; 275(2):L365-71. DOI: 10.1152/ajplung.1998.275.2.L365. View

Holmes A, Abraham D, Chen Y, Denton C, Shi-Wen X, Black C . Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J Biol Chem. 2003; 278(43):41728-33. DOI: 10.1074/jbc.M305019200. View

Leask A, Holmes A, Black C, Abraham D . Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem. 2003; 278(15):13008-15. DOI: 10.1074/jbc.M210366200. View

10.

Lau L, Lam S . The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res. 1999; 248(1):44-57. DOI: 10.1006/excr.1999.4456. View

11.

Hinz B, Phan S, Thannickal V, Galli A, Bochaton-Piallat M, Gabbiani G . The myofibroblast: one function, multiple origins. Am J Pathol. 2007; 170(6):1807-16. PMC: 1899462. DOI: 10.2353/ajpath.2007.070112. View

12.

Shiwen X, Rajkumar V, Denton C, Leask A, Abraham D . Pericytes display increased CCN2 expression upon culturing. J Cell Commun Signal. 2009; 3(1):61-4. PMC: 2686756. DOI: 10.1007/s12079-009-0053-7. View

13.

Liu S, Kapoor M, Denton C, Abraham D, Leask A . Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model. Arthritis Rheum. 2009; 60(9):2817-21. DOI: 10.1002/art.24801. View

14.

Yamamoto T, Takagawa S, Katayama I, Yamazaki K, HAMAZAKI Y, Shinkai H . Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol. 1999; 112(4):456-62. DOI: 10.1046/j.1523-1747.1999.00528.x. View

15.

Blom I, Goldschmeding R, Leask A . Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?. Matrix Biol. 2002; 21(6):473-82. DOI: 10.1016/s0945-053x(02)00055-0. View

16.

Gao R, Brigstock D . Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem. 2003; 279(10):8848-55. DOI: 10.1074/jbc.M313204200. View

17.

Holmes A, Abraham D, Sa S, Shiwen X, Black C, Leask A . CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem. 2001; 276(14):10594-601. DOI: 10.1074/jbc.M010149200. View

18.

Van Beek J, Kennedy L, Rockel J, Bernier S, Leask A . The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther. 2006; 8(2):R36. PMC: 1526589. DOI: 10.1186/ar1890. View

19.

Kuiper E, Witmer A, Klaassen I, Oliver N, Goldschmeding R, Schlingemann R . Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina. Br J Ophthalmol. 2004; 88(8):1082-7. PMC: 1772287. DOI: 10.1136/bjo.2003.032045. View

20.

Desmouliere A, Chaponnier C, Gabbiani G . Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005; 13(1):7-12. DOI: 10.1111/j.1067-1927.2005.130102.x. View